Answer
As a recombinant protein, agalsidase beta can trigger IgG antibodies. People with antibodies have a greater likelihood of infusion-associated reactions, so antibody status and clinical tolerance may require review.
Sources for this answer
- Fabrazyme 35mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.